Immunotoxins specific for the CD80 and CD86 antigens were prepared by linking three type 1 ribosomeinactivating proteins (RIPs), namely bouganin, gelonin and saporin-S6, to the monoclonal antibodies M24 (anti-CD80) and 1G10 (anti-CD86). These immunotoxins showed a specific cytotoxicity for the CD80/CD86-expressing cell lines Raji and L428. The immunotoxins inhibited protein synthesis by target cells with IC 50 s (concentration causing 50% inhibition) ranging from 0´25 to 192 pmol/l as RIPs.
In addition to the presentation of antigen, T cells require additional or`co-stimulatory' signals from antigen-presenting cells (APCs). Co-stimulation is neither antigen specific nor MHC restricted and can be mediated via a large number of cell-surface molecules expressed on APCs (Schultze et al, 1996) . Although adhesion and antigen recognition are necessary, they are not sufficient to induce a full immune response. Moreover, engagement of the T-cell receptor by an antigen in the absence of co-stimulation fails to induce T-cell activation, but results instead in the induction of anergy (Schultze et al, 1996) . A large number of studies (reviewed in Somoza & Lanier, 1995; Lenschow et al, 1996; Schultze et al, 1996; McAdam et al, 1998) indicate that the most important regulatory signal for T-cell activation is the interaction between CD80 (B7-1) and CD86 (B7-2) on APCs with CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) on T cells. CD80 and CD86 are transmembrane proteins of 60 kDa and 75 kDa, respectively, that belong to the immunoglobulin gene superfamily and share a 25% amino acid homology (Azuma et al, 1993; Freeman et al, 1993) . Under physiological conditions, CD80 and CD86 expression is tightly controlled and is restricted to cells with an antigen-presenting function, including dendritic cells, monocytes and activated B cells (Lenschow et al, 1996) . Moreover, a strong expression of the CD80 activation antigen has been described on most Hodgkin and Reed± Sternberg (H±RS) cells independently of the histological subtype, whereas the CD86 antigen appears widely expressed on H±RS cells, particularly in the histological subtypes showing mixed cellularity or nodular sclerosis (Gruss & Kadin, 1996; van Gool et al, 1997) .
As B7 molecules play a critical role in determining T-cell activation vs. anergy, much attention has been devoted to manipulation of this co-stimulatory pathway for therapeutic purposes (van Gool et al, 1995) . Immunotherapy with monoclonal anti-B7 antibodies could be utilized either for the suppression of the immune system [autoimmune diseases, transplant rejections and graft-versus-host disease (GVHD)] or for its stimulation (vaccinations and tumours).
Immunotherapy based on the delivery of toxins towards specific cell targets using monoclonal antibodies may be considered an exciting modality in the therapy of many malignancies. Immunotoxins are chimaeric proteins consisting of a toxin coupled to an antibody by either chemical conjugation or genetic engineering. To this purpose, a variety of bacterial and plant toxins have been utilized (Kreitman & Pastan, 1998) . Among the plant toxins there are the ribosome-inactivating proteins (RIPs) which can be divided into type 1 (consisting of single-chain proteins) and type 2 (consisting of an enzymatic A-chain linked to a B-chain with lectin property). Type 1 RIPs and the A-chain of type 2 RIPs are RNA N-glycosidases that cleave one or more adenine molecules from ribosomal RNA, thus damaging the ribosome irreversibly (reviewed in Barbieri et al, 1993) . Immunotoxins can be made with either type 1 or type 2 RIPs or with the active chains of the latter, ricin A-chain being the most widely used. To date, several clinical trials have been conducted (some still ongoing) to evaluate the anti-tumour efficacy of immunotoxins made with RIPs. The response rates observed in phase I/II trials have been often higher than those reported for some of the conventional anti-blastic drugs (Trush et al, 1996; Kreitman & Pastan, 1998 ). An immunotoxin prepared with saporin, a single-chain RIP, and an anti-CD80 (B7-24) monoclonal antibody was selectively cytotoxic to CD80 1 cells (Vooijs et al, 1997) . In this report, we describe six different immunotoxins made with an anti-CD80 (M24) and an anti-CD86 (1G10) monoclonal antibody and three different RIPs (bouganin, gelonin and saporin). The ability of these immunotoxins to eliminate target cells while sparing the human haemopoietic progenitors was evaluated utilizing two human CD80-and CD86-positive cell lines (L428 and Raji) and CD34 1 cells purified from peripheral blood.
MATERIALS AND METHODS

Monoclonal antibodies (mAbs). Murine IgG1 mAbs M24
(anti-human CD80) and 1G10 (anti-human CD86) were kindly provided by Innogenetics (Gent, Belgium).
The IgG1 monoclonal antibodies B-B10 (anti-CD25) (Tazzari et al, 1992a) and Ber-H2 (anti-CD30) (Tazzari et al, 1992b) were used as isotype-matched irrelevant antibodies for L428 and Raji cell lines respectively. The same antibodies were coupled to saporin to obtain irrelevant immunotoxins. A fluorescein isothiocyanate-conjugated goat anti-mouse IgG (FITC±GAM) (Coulter Immunology, Hiaileah, Florida, USA) was used as a second step reagent for immunofluorescence staining.
Ribosome-inactivating proteins. The type 1 ribosomeinactivating proteins gelonin and saporin (saporin-S6), from the seeds of Gelonium multiflorum and Saponaria officinalis, respectively, were purified, as previously described (Barbieri et al, 1987) . Bouganin, another type 1 RIP, was purified from the leaves of Bougainvillea spectabilis, as reported by Bolognesi et al (1997) . All RIPs were labelled with 125 I with the Iodogen reagent (Pierce Chemical, Catex, USA), according to the manufacturer's instructions.
Immunotoxins. The RIPs and the mAbs were conjugated via a disulphide bond between chemically inserted sulphydryl groups. Antibody and RIP, the latter containing a trace of [
125 I]-RIP, were dissolved in 50 mmol/l sodium borate buffer, pH 9´0, at a concentration of 1±7 mg/ml and were modified by adding 2-iminothiolane (Sigma, St Louis, MO, USA) to a final concentration of 0´6 mmol/l (antibody) or 1´0 mmol/l (RIP). After 60 min at 288C, glycine was added to a final concentration of 200 mmol/l and, after a further 15 min at room temperature (218C), Ellman's reagent, dissolved in 50 ml of dimethylformamide, was added to a final concentration of 2´5 mmol/l. After 10 min at room temperature, or immediately in the case of gelonin, the modified proteins were separated from unreacted reagents by a gel filtration on a Sephadex G25 column (30 cm Â 1´6 cm) (Pharmacia, Uppsala, Sweden). The number of sulphydryl groups introduced was determined by the absorbance at 412 nm (A 412 ) before and after reduction with 20 mmol/l 2-mercaptoethanol, as described by Ellman (1959) . The modified RIP was reduced with 20 mmol/l 2-mercaptoethanol, filtered as above through a Sephadex G25 column and collected directly onto the unreduced derivatized monoclonal antibody. The RIP/antibody mixture in a 10:1 molar ratio was allowed to react for 16 h at room temperature. The resulting conjugate was separated from the unreacted reagents and from ribosome-inactivating protein homopolymers by gel filtration on a Sephacryl S200 high-resolution column (100 cm Â 2´5 cm) (Pharmacia), equilibrated and eluted with phosphate-buffered saline (PBS; 0´14 mol/l sodium chloride in 5 mmol/l sodium phosphate buffer, pH 7´4). The RIP/antibody ratio of each immunotoxin was estimated by the [ 125 I]-RIP radioactivity and by the protein concentration calculated from the A 280 .
The protein synthesis inhibitory activity of the pooled fractions was assayed on a rabbit reticulocyte lysate, as described below. The conjugates were sterilized by filtering through a 0´22-mm filter, divided into aliquots and stored in liquid nitrogen at mmol/l concentrations as RIP.
Cell lines. The activity of the conjugates was assayed on the CD80/CD86-positive cell lines Raji (derived from a Burkitt's lymphoma) and L428 (derived from a Hodgkin's lymphoma). Aspecific toxicity was tested on the CD80/ CD86-negative cell line T24, originated from an explant of a grade 3 transitional cell carcinoma of the bladder.
Cells were maintained in RPMI-1640 medium (Gibco, Life Technologies, Rockville, MD, USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (Biospa, Milano, Italy), 2 mmol/l l-glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin (Bio Whittaker, Verviers, Belgium) in humidified air under 5% CO 2 at 378C. Viability was checked before each experiment by the trypan blue dye exclusion method. mAbs affinity for CD80-and CD86-expressing cell lines. The antigen expression of the target cell lines and the reactivity with each immunotoxin was ascertained by an indirect immunofluorescence method. Briefly, Raji and L428 cells were harvested and adjusted to a concentration of 10 6 cells/ml in complete RPMI-1640 medium. To 100 ml of cell suspension, 100 ml of scalar dilutions (from 0´005 nmol/l to 10 nmol/l) were added of the M24 (anti-CD80) or 1G10 (anti-CD86) mAb, free or conjugated to bouganin, gelonin or saporin. Negative samples were run with the reported isotype-matched irrelevant anti-CD25 and anti-CD30 mAbs and control samples were run with medium alone. Cells were incubated for 20 min at room temperature (218C), washed twice in PBS, pH 7´4, containing 1% FBS and incubated again for 10 min at room temperature in a volume of 50 ml with 2 ml of FITC±GAM. After three washings with PBS containing 1% FBS, the samples were fixed with PBS containing 1% formalin. Binding of mAbs and immunotoxins was assessed by flow cytometry with Epics XL equipment (Coulter). Histograms and statistics were generated with the software of the Epics-dedicated computer. The intensity of fluorescence, evaluated as mean channel value (MCV), was used as a measure of the binding capacity of the antibody alone or of the corresponding immunotoxins. The adherent T24 cells were mechanically harvested by a scraper and analysed for CD80 and CD86 expression by flow cytometry, as described above.
Protein synthesis inhibition assays. The inhibitory activity of immunotoxins on cell-free protein synthesis was evaluated with a rabbit reticulocyte lysate prepared as described by Allen & Schweet (1962) . Immunotoxins were reduced before use with 20 mmol/l 2-mercaptoethanol for 30 min at 378C, appropriately diluted and then added to a reaction mixture containing, in a final volume of 62´5 ml, 10 mmol/l tris-HCl buffer, pH 7´4, 100 mmol/l ammonium acetate, 2 mmol/l magnesium acetate, 1 mmol/l ATP, 0´2 mmol/l GTP, 15 mmol/l phosphocreatine, 3 mg of creatine kinase, 0´05 mmol/l amino acids (minus leucine), 3´3 kBq of l-[
14 C]-leucine (Amersham International, Bucks, UK) and 25 ml of a rabbit reticulocyte lysate. Incubation was at 288C for 5 min. The reaction was arrested with 1 ml of 0´1 mol/l potassium hydroxide, and two drops of hydrogen peroxide and 1 ml of 20% (w/v) of trichloroacetic acid was added. Precipitated proteins were collected on glass-fibre discs and the radioactivity incorporated was measured with a b-counter (Beckman, Fullerton, CA, USA) after the addition of 5 ml of Ready Gel scintillation cocktail (Beckman) containing 0´7% acetic acid. Each experiment was carried out in duplicate. The concentration of immunotoxins, expressed as RIP content, causing 50% inhibition of leucine incorporation (IC 50 ) was calculated by linear regression analysis.
The cytotoxicity of the immunotoxins was evaluated from the inhibition of [ 3 H]-leucine incorporation. Raji and L428 cells were harvested, checked for viability and adjusted to a concentration of 10 5 cells/ml in complete RPMI-1640 medium. Cells (10 4 ) were seeded in 96-well microtitre plates (Falcon, Becton Dickinson, Franklin Lakes, NJ, USA) in a 100-ml volume and 100 ml of M24-containing immunotoxins or 1G10-containing immunotoxins or a mixture of the two immunotoxins were added to final concentrations ranging from 0´1 pmol/l to 10 000 pmol/l as RIP. Parallel samples were run with a RIP alone (from 0´1 pmol/l to 1 mmol/l), anti-CD80 mAb alone, anti-CD86 mAb alone and a mixture of unconjugated anti-CD80, anti-CD86 and RIP. Anti-CD30/saporin and anti-CD25/saporin conjugates were used as irrelevant immunotoxins for Raji and L428 cells respectively. After 72 h, 74 kBq of l- [4,5- 3 H]-leucine (Amersham) was added and, after a further 18 h, cells were harvested with an automatic cell harvester (Skatron Instruments, Lier, Norway) onto glassfibre diskettes. The radioactivity incorporated was determined as described above.
The CD80-and CD86-negative T24 cells were trypsinized and seeded in 24-well plates (2 Â 10 4 cells/well in 0´5 ml) and used as non-target cells. After 24 h, the medium was removed and substituted with medium containing scalar concentrations of immunotoxins (from 0´01 nmol/l to 10 nmol/l as RIP). After 48 h of incubation, [
3 H]-leucine (74 kBq) was added in 100 ml of RPMI and, after a further 18 h, cells were fixed by adding 1 ml of 20% trichloroacetic acid. After three washes with 5% trichloroacetic acid, cells were lysed with 250 ml of 0´1 mol/l potassium hydroxide for 10 min at 378C. The radioactivity was measured as described above. Each experiment was run in triplicate. Results are expressed as the mean of three different experiments, with a SD # 10%.
Evaluation of apoptosis by propidium iodide staining. CD80 1 and CD86 1 Raji and L428 cells were continuously exposed to 1 nmol/l bouganin and saporin conjugated to either anti-CD80 or anti-CD86 mAbs for 4, 8, 16, 24, 48, 72 and 96 h. Experiments were performed essentially as previously described (Bolognesi et al, 1996 (Bolognesi et al, , 1998 . Controls with a mixture of each RIP and the two mAbs or the medium alone were run in parallel. CD80 2 and CD86 2 T24 cells were exposed for 48, 72 and 96 h to the immunotoxins at same nmol/l concentration. The cells were then trypsinized and treated as described for Raji and L428 cell lines. CD34 1 cell purification. Human blood mononuclear cells (from healthy volunteers) were obtained by gradient separation (Lymphoprep, 1077 g/l, Nycomed Pharma, Oslo, Norway). Light-density cells were washed twice in PBS with 1% bovine serum albumin (BSA; Sigma) and CD34 1 cells were highly purified by MiniMacs high-gradient magnetic separation column (Milteny Biotec, Bergisch Gladbach, Germany) . To assess the percentage of CD34 1 elements, aliquots of CD34 1 target cells were restained with the HPCA-2 antibody (IgG 1a ±FITC, Becton Dickinson) directed towards an epitope of CD34 antigen different from the one targeted by the Qbend10 mAb used with the MiniMacs system. Briefly, CD34
1 cells were incubated for 30 min in the dark at 48C with HPCA-2± FITC. Propidium iodide (2 mg/ml) was added to detect nonviable cells, which were excluded from analysis. After two washes in PBS/BSA, flow cytometric analysis was performed on a gated population set on scatter properties by using 
RIPs and mAbs were derivatized by insertion of sulphydryl groups with 2-iminothiolane at concentrations of 0´6 mmol/l (antibody) or 1´0 mmol/l (RIP). The RIP/mAb ratio was calculated by [ 125 I]-RIP radioactivity and by protein concentration. IC 50 is the concentration (expressed as RIP content) inhibiting protein synthesis by 50% in 1 ml of a rabbit reticulocyte lysate reaction mixture.
* Free, underivatized RIP. ² As RIP. 10 000 events were collected in list mode on FACScan software. In all experiments, the purity of CD34 1 cells was . 90% and the recovery . 80% .
Colony assays. Purified CD34 1 cells were cultured in semisolid medium, as previously described (Tazzari et al, 1994) , after 1 h incubation with 0´001±100 nmol/l immunotoxins, mAbs or RIPs. Briefly, 5 Â 10 3 cells were plated in duplicate in culture medium consisting of 1 ml of Iscove's modified Dulbecco's medium (IMDM) supplemented with 24% FBS, 0´8% BSA, 10 24 mol/l 2-mercaptoethanol, 2 U of human recombinant erythropoietin (Dompe Á Biotec, Milan, Italy) and 0´2 mmol/l bovine haemin. To measure the optimum clonogenic efficiency, 10% (v/v) of a selected batch of a phytohaemagglutinin±lymphocyte-conditioned medium (PHA-LCM) was added. Methylcellulose final concentration was 1´1%. The colony-forming unit cells (CFU-C), consisting of granulocyte±macrophage colonyforming unit (CFU-GM), erythroid progenitors (BFU-e) and mixed colonies (CFU-GEMM), were scored after 14 d of incubation at 378C in a fully humidified 5% CO 2 atmosphere. The clonogenic efficiency of CD34 1 cells was 7^3%. The toxicity of short-term exposure to the anti-CD80 and anti-CD86 immunotoxins was also tested on the clonogenic activity of L428 and Raji cell lines. Briefly, cells were incubated for 1 h with 0´001±100 nmol/l immunotoxins, mAbs or RIPs. After two washes, 2 Â 10 3 tumour cells were plated in IMDM supplemented with 10% FBS and 1% glutamine and antibiotics. Methylcellulose was added to a final concentration of 1´1%. Aggregates . 50 cells were scored with an inverted microscope after 7 d of culture. 
LTC-IC assay. The number of long-term culture-initiating cells (LTC-ICs) was determined from purified CD34
1 cells after 1 h of incubation with 100 nmol/l immunotoxins, mAbs or RIPs, as previously described (Fogli et al, 1998) . After 5 weeks in culture, non-adherent and adherent cells were pooled, washed and plated together in methylcellulose for the determination of total progenitor cell content (CFU-C) and the number of LTC-ICs was scored after 14 d of incubation, as reported above.
RESULTS
Immunotoxins
Six different immunotoxins were prepared with two monoclonal antibodies, namely M24 (anti-CD80) and 1G10 (anti-CD86), and three different single-chain RIPs (bouganin, gelonin and saporin) conjugated to the antibodies by an artificial disulphide bond. Sulphydryl groups were inserted in each type of molecule by an imidoester reaction between 2-iminothiolane and the primary amino groups of the proteins. Both antibodies showed a marked reactivity with 2-iminothiolane, with an average of more than 2´5 SH groups inserted per molecule, using a standard concentration of the linking reagent. The three RIPs were less reactive and, among them, bouganin showed the lowest and saporin the highest derivatization grade (Table I) . After conjugation the toxin±antibody molar ratio was about 2´5 for the anti-CD86 immunotoxins, whereas those containing the anti-CD80 mAb gave more variable products, with the toxin± antibody molar ratio ranging from 2´11 to 3´67.
The inhibitory activity of native and conjugated RIPs on protein synthesis by a rabbit reticulocyte lysate is also reported in Table I . A loss of activity on conjugation, ranging from 1´4-to 2´9-fold, was observed with all RIPs. Saporin still retained the highest protein synthesis inhibitory activity after conjugation.
mAbs affinity for CD80-and CD86-expressing cell lines
The anti-CD80 M24 mAb and the anti-CD86 1G10 mAb used in this study both reacted with Raji and L428 cell lines. In Fig 1, the mean fluorescence intensity is plotted against the concentration of free or conjugated antibodies. These curves show a higher expression of CD80 and CD86 antigens on L428 (Fig 1A and B) than on Raji (Fig 1C  and D) cells. After conjugation, the anti-CD80 monoclonal antibody retained the same antigen-binding properties of the native antibody, whereas the anti-CD86 monoclonal antibody showed some loss of affinity, more evident on the Raji cell line.
The T24 cell line did not react with either anti-CD80 or anti-CD86 mAbs.
Inhibition of protein synthesis by cells All tested immunotoxins inhibited [
3 H]-leucine incorporation by Raji and L428 cell lines (Fig 2) . RIPs incremented their toxicity on Raji cells by 3±4 log upon conjugation with 1G10 mAb (anti-CD86) and by 4±5 log upon conjugation with M24 mAb (anti-CD80) (Table II) . On L428 cells, the pattern of toxicity was the same, but the increase of RIPs' cytotoxicity upon conjugation was 1 log lower than on Raji cells (Table II) . No toxicity was observed with free mAbs. The anti-CD80/saporin and anti-CD86/saporin immunotoxins were the most active on cell lines, with IC 50 s ranging from 0´25 pmol/l to 5´84 pmol/l. The immunotoxins made with bouganin and gelonin showed IC 50 s in the 129±192 pmol/l range when linked to anti-CD86 mAb and in the 4´61±56´5 pmol/l range when conjugated to anti-CD80 mAb.
The immunotoxins containing anti-CD80 mAb were more active than the corresponding anti-CD86-containing immunotoxins, whereas the mixture of the two types of immunotoxins showed an intermediate toxicity. This pattern was observed with immunotoxins containing bouganin, gelonin or saporin and in both Raji and L428 cell lines. Bouganin was chosen for further studies, in comparison with saporin, for its very low toxicity in vivo .
Protein synthesis by the non-target T24 cell line was not affected by immunotoxins, but by anti-CD80/saporin that inhibited protein synthesis only at the highest concentration tested (Table II) .
Induction of apoptosis
The exposure of Raji and L428 cells to 1 nmol/l bouganinand saporin-containing immunotoxins induced fragmentation and loss of DNA. These apoptotic changes appeared to increase with time (Fig 3) . The loss of DNA for both cells was not detectable before 16±24 h. After incubation with immunotoxins containing bouganin, the percentage of hypodiploid cells increased linearly until 96 h of incubation, reaching values of 50±70% in all cases, whereas in Raji cells incubated with anti-CD86/bouganin the percentage of apoptotic cells did not exceed a 30% plateau, which was reached at 48 h. Immunotoxins containing saporin produced strand breaks at the highest rate between 16 h and 24 h of incubation, then apoptosis continued to increase throughout the 96 h of observation. These immunotoxins induced apoptosis in a significantly higher percentage of cells than the corresponding immunotoxins containing bouganin. These experiments also indicate that the anti-CD80 mAb targets RIPs more efficiently than the anti-CD86 mAb. No significant increase of apoptosis over controls was induced by exposing the cells to a mixture of free antibodies and RIP (Fig 3) . Immunotoxins, at the same nmol/l 
Colony assays on tumour cell lines
To evaluate the potential anti-tumour activity of anti-CD80 and anti-CD86 immunotoxins containing saporin and bouganin, the clonogenicity of Raji and L428 cell lines was determined after a short-term exposure (1 h) to the immunotoxins. A complete elimination of L428 clones was reached with the immunotoxins (Fig 4A and B) . Both saporin-containing immunotoxins at 1 nmol/l concentration completely inhibited colony growth. The same level of inhibition was obtained with 10 nmol/l anti-CD80/bouganin and 100 nmol/l anti-CD86/bouganin. The anti-CD80 immunotoxins appeared more active on L428 cells than the anti-CD86 ones, independently of the RIP used.
All immunotoxins were less effective on Raji cells (Fig 4C  and D) . The immunotoxins containing saporin were not active at concentrations up to 0´1 nmol/l. The anti-CD80/ saporin produced a complete elimination of Raji clones at a concentration of 10 nmol/l, whereas with the anti-CD86/ saporin and anti-CD80/bouganin the same result was obtained only at the highest concentration tested (100 nmol/l). The anti-CD86/bouganin did not produce a complete inhibition even at the highest concentration tested.
The mixture of anti-CD80 and anti-CD86 immunotoxins did not show any synergistic effect (data not shown). Free RIPs or mAbs gave no inhibition of clonogenic growth.
Toxicity to committed haemopoietic progenitor cells
The toxicity of mAbs, RIPs and immunotoxins was evaluated on the colony-forming activity of CD34 1 haemopoietic stem cells. A short-term exposure (1 h) to bouganin and related immunotoxins up to 100 nmol/l concentrations did not significantly affect the CFU-C recovery. The saporin-containing immunotoxins showed some toxicity at concentrations $ 1 nmol/l (Fig 5) . Saporin alone produced a 42% inhibition of CFU-C at 100 nmol/l. No effect was shown by incubation with the free mAbs. Toxicity to primitive haemopoietic stem cells No significant toxicity was observed for the more immature CD34 1 cells incubated with mAbs, RIPs and immunotoxins tested at the highest concentration (100 nmol/l) (Fig 6) . In addition, the LTC-IC assay did not reveal any toxicity of saporin and related immunotoxins, which were toxic for more committed CD34
1 clonogenic cells at this concentration.
DISCUSSION
Immunotoxins are potent reagents useful in killing cell populations bearing selected antigens. These tools have been devised for the immunotherapy of tumours and would be particularly suitable for eliminating residual neoplastic disease after chemoradiotherapy. They could also be used for GVHD prevention and treatment, both for ex vivo and in vivo use, provided that normal cells and tissues are spared. The anti-CD80 and anti-CD86 mAbs could be optimal carriers for immunotoxins as the related antigens are usually restricted to H±RS cells and to APCs. Thus, it could be possible to devise a strategy for the in vivo therapy of Hodgkin's disease by using anti-CD80-and anti-CD86-containing immunotoxins or for ex vivo purging of both bone marrow and/or peripheral blood stem cells. Moreover, other possible uses of our conjugates could be to kill APCs both ex vivo and in vivo, to prevent and/or cure GVHD in allogenic stem cell grafts as well as to prevent rejection during solid organ transplants. The last strategy has been highlighted by the recent trials utilizing a hybrid mouse± human molecule CTLA4-Ig, designed to inhibit the CD80/ CD86±CD28/CTLA-4 co±stimulatory interactions (van Gool et al, 1995; Kirk et al, 1997) . This approach should be able to induce anergy in the responsive cells, as the interaction between CD80/CD86-positive APCs with T lymphocytes would be blocked. The use of anti-CD80/ CD86 immunotoxins could be more efficient, as they should be able selectively to kill activated allogenic CD80 1 /CD86 1 APCs only. Depletion of APCs would cause or aggravate an immunodeficiency condition. However, the toxicity of anti-CD80/CD86-containing conjugates on haemopoietic precursors appears to be very low, both on committed and primitive' precursors, as demonstrated by the present results and consistent with the negligible CD80/CD86 expression on haemopoietic precursors (Shaw, 1997) . Thus, the APCs could regenerate and the immunodeficiency would be transient. RIPs incremented their toxicity on target cells by 3±4 log upon conjugation, as measured by inhibition of protein synthesis. The RIP targeting toward the CD80 antigen resulted in the highest cytotoxic effect, probably reflecting a better preservation of immunoreactivity of the M24 antibody upon conjugation. This difference was more evident by using bouganin as the toxic agent, suggesting also differences in steric hindrance and/or internalization. The cocktail of anti-CD80 and anti-CD86 immunotoxins did not show additive cytotoxic effects, but rather an intermediate toxicity.
Saporin-containing immunotoxins appeared to be the most potent reagents, even more than previously observed with an immunotoxin prepared with a different anti-CD80 antibody (Vooijs et al, 1997) . In fact, they were the most efficient in killing both L428 and Raji cells, as shown by protein synthesis inhibition and clonogenic tests. The difference in cytotoxicity between saporin and the other RIPs cannot be explained only on the basis of the ribosomedamaging activity after conjugation. In fact, in the cell-free system, the immunotoxins containing saporin were 3-to 8´6-fold more toxic with respect to those containing other RIPs, whereas for target cells' protein synthesis this ratio increased to 18-to 223-fold. These data could suggest different internalization and/or intracellular routing.
Saporin, alone or mixed to free antibodies, showed some toxicity at the highest concentration tested and the same result was obtained by testing immunotoxins on non-target cells (Table II) . Free bouganin and gelonin were less toxic than saporin, inhibiting protein synthesis at a concentration 0´5±1´5 log higher. The same difference was observed in the activity of the corresponding immunotoxins, those containing saporin being more toxic by 1±2 log than the others (Table II) .
Immunotoxins containing saporin and bouganin induced apoptosis of target cells maintaining the difference observed between anti-CD80 and anti-CD86 conjugates. Also the immunotoxins containing bouganin showed a slower enhancement of the hypodiploid peak. These differences only in part reflect the protein synthesis inhibitory properties, as the anti-CD80/bouganin at 1 nmol/l concentration lowered to zero protein synthesis as with saporin immunotoxins, but caused a lower extent of apoptosis. Moreover, the anti-CD80/bouganin immunotoxin completely blocked the clonogenic growth of both cell lines, although at a concentration 1 log higher than the anti-CD80/saporin. Probably, the main difference between the last two immunotoxins resides in the apoptosis kinetics, being slower in the case of anti-CD80/bouganin. The lack of a complete correspondence between the inhibition of protein synthesis and the inhibition of clonogenic growth was also evident for the immunotoxins containing saporin, which completely inhibited protein synthesis on both cell lines but which were less active in killing Raji clones. Recently, a double mechanism of cell killing, including inactivation of EF-2 and caspase activation, has been reported for the genetically engineered immunotoxin B3(Fv)-PE38 (Keppler-Hafkemeyer et al, 1998). The results described here could be in agreement with such a double mechanism: one requiring the inactivation of ribosomes through deadenylation of 28s rRNA and the other inducing apoptosis by caspase activation (Komatsu et al, 1998) or possibly by direct damage on DNA, actually verified only in a cell-free system .
Immunotoxins containing bouganin are less toxic than those prepared with saporin, as shown by their effects on committed haemopoietic progenitor (Fig 5) and non-target cells (Table II) . Thus, immunotoxins containing bouganin may be preferable for clinical use, although in vivo trials with saporin-containing immunotoxins showed an acceptable general toxicity in patients (Falini et al, 1992) .
The present results indicate that anti-CD80-targeted saporin and bouganin are powerful anti-tumour agents, whereas anti-CD86 immunotoxins are less effective, especially when the toxin moiety is bouganin. No synergistic effect was observed utilizing a cocktail of anti-CD80 and anti-CD86 conjugates. However, as these antigens are widely expressed on Hodgkin and Reed±Sternberg cells, the simultaneous administration will avoid mutant selection for one of the recognized epitopes. At present, these immunotoxins could be safely used for ex vivo bone marrow treatment, whereas further in vivo biodistribution, pharmacokinetic and systemic toxicity studies will be required before their use in clinical trials.
Our data also indicate that bouganin might represent a very interesting new toxic molecule, being resistant to chemical derivatization and being effective when specifically targeted. These properties, together with a very low toxicity in vivo , indicate that bouganin is worthy of consideration for the preparation of immunotoxins for therapeutic purposes.
